Drugs that contain Spironolactone

1. Drug name - CAROSPIR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9757394 CMP DEV LLC Spironolactone aqueous formulations Oct, 2036

(14 years from now)

US10493083 CMP DEV LLC Spironolactone aqueous compositions Oct, 2036

(14 years from now)

US10888570 CMP DEV LLC Spironolactone aqueous compositions Oct, 2036

(14 years from now)

US10660907 CMP DEV LLC Spironolactone aqueous compositions Oct, 2036

(14 years from now)

US10624906 CMP DEV LLC Spironolactone aqueous compositions Oct, 2036

(14 years from now)

Treatment: Carospir is indicated for treatment of nyha class iii-iv heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure

Dosage: SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
25MG/5ML SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.